Chicago—November 5, 2011
A study being presented Sunday, Nov. 6 at the 2011 Annual Scientific Meeting of the American College of Rheumatology in Chicago, finds that many lupus patients with low socioeconomic status are unable to attend scheduled appointments with physicians due to daily obstacles.
"Lupus is a systemic autoimmune disease that requires continuous monitoring of the disease activity and the effects medications may be having on someone," explained Doruk Erkan, M.D., senior author, rheumatologist and clinical co-director at the Mary Kirkland Center for Lupus Care at Hospital for Special Surgery. "Missing an appointment, and thus staying on a medical course without re-evaluating a patient's health status, could cause these individuals avoidable harm."
The researchers examined lupus patients who also had low socioeconomic status at the Mary Kirkland Center for Lupus Care at Hospital for Special Surgery, and found that challenges of socioeconomic status played a large part in causing some of the patients to miss their appointments. The top two reasons for missing their appointment was due to tardy or unreliable transportation, such as ambulettes, or because of insufficient childcare.
"Most of these lupus patients are women," explained Pretima Persad, MPH, lead author of the study and the manager of the Mary Kirkland Center for Lupus Care. "If their childcare falls through, they put their child first and decide to cancel appointments, which can then affect their healthcare."
During the first phase of the study, the research team studied 143 patients and categorized these individuals into three classes, based on the number of appointments they missed. They found that seven patients were "poor" attendees – attending only 1-30 percent of their appointments; 66 patients were "average" attendees – attending 31-70 percent of their appointments; and 71 patients were "good" attendees – attending 71-100 percent of their appointments.
After excluding the "poor" group from their calculations, because there were too few to be statistically significant, the researchers found that the "average" and "good" attendees had an overall appointment compliance rate of 67 percent.
During the second phase of the study, for the purpose of improving the appointment compliance rate among these patients, motivational, reminder phone calls were made the day prior to their appointments. After this intervention, 69 percent of patients attended their appointments, which showed that the reminder-call had no statistically significant effect on behavior.
"This proved that these patients weren't missing their appointments because of forgetfulness, and shows that there are other factors that prevented them from arriving on the day of their appointment that they could not predict," explained Persad.
After following up with patients who missed their appointments, the researchers found that 44 percent of these individuals cited transportation, and 19 percent claimed that child care were the top two reasons for missing their appointments.
"From this study, we now can say that these patients have social obstacles that are the real issue, it's not that they are forgetful, or that they do not take their own medical care seriously," said Dr. Erkan. "Improving transportation services or temporary childcare for these patients is potentially an important approach to ensure that this patient population receives the attentive care they need and deserve."
A common and potentially dangerous health concern for these individuals is kidney inflammation, because, in lupus patients, the body's own immune system may attack different organs including kidneys. If not monitored regularly, someone with lupus might be faced with kidney malfunction without experiencing any pain. Regular urine and blood testing, at least every three months in patients who are deemed by their rheumatologist to have relatively active lupus, is important to monitor kidney involvement, explained Kyriakos A. Kirou, M.D., DSc, FAC, co-author of the study and clinical co-director at the Mary Kirkland Center for Lupus Care at Hospital for Special Surgery.
"It's possible that these patients are doing fine, but it's also possible that they are getting sick internally, without having any significant symptoms," explained Dr. Kirou. "They could be in dire need of medical attention without knowing it."
The Mary Kirkland Center for Lupus Care provides lupus patients with comprehensive, multidisciplinary assessments, support programs and access to clinical trials. For more about the center, please visit www.hss.edu/lupuscenter.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.